HAYWARD, Calif., Jan. 5, 2012 /PRNewswire/ -- Molecular diagnostics company GenturaDx announced today that the company will present at the Biotech Showcase Conference on Monday, January 9 at 9:15 a.m. Pacific Time at the Parc 55 Wyndham Hotel in San Francisco.
Mark Bagnall, president and CEO of GenturaDx, will provide an update on the company and the IDbox™ system. The company is currently in beta studies with clinical trials to start mid-2012.
GenturaDx is a molecular diagnostic company focused on making high-performance molecular diagnostics both affordable and practical for any laboratory to perform. The company is developing a fully integrated, automated instrument that conducts testing using a single-use cassette. This platform will make rapid, high-quality molecular diagnostics accessible to hospitals and patients worldwide – circumventing long-standing barriers of costs, automation and performance. GenturaDx's compact, self-contained platform incorporates sample preparation with proprietary, real-time PCR amplification and detection, reducing the risk of contamination and saving time. The platform's unique engineering design and intuitive interface relies on semi-batch processing capability while improving clinical value by offering multiple molecular targets in a single test. For more information, go to www.GenturaDx.com.
Copyright©2010 PR Newswire.
All rights reserved